Atlas Trials

Efficacy and Tolerability of Grazoprevir and Elbasvir in Patients With Chronic Genotype 1 HCV and HIV Co-infection

Clinical trial NCT03098121 · COMPLETED

Trial details

NCT number
NCT03098121
Sponsor
Taoyuan General Hospital
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Chronic Hepatitis C
Start date
2017-10-20
Primary completion
2018-11-30
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.